Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO
7/22/2014 7:21:13 AM
Loxo Oncology, a biotech developing small molecule therapeutics to treat solid tumors, announced terms for its IPO on Monday. The Stamford, CT-based company plans to raise $57 million by offering 4.4 million shares at a price range of $12 to $14. At the midpoint of the proposed range, it would command a fully diluted market value of $211 million.
Help employers find you! Check out all the jobs and post your resume.
comments powered by